Lundbeck
HLUN-B.CO
#2793
Rank
A$8.72 B
Marketcap
A$9.19
Share price
-4.45%
Change (1 day)
-2.98%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

EPS for Lundbeck (HLUN-B.CO)

EPS in 2025 (TTM): A$0.93

According to Lundbeck's latest financial reports the company's current EPS (TTM) is A$0.87. In 2024 the company made an earnings per share (EPS) of A$0.63 an increase over its 2023 EPS that were of A$0.49.

EPS history for Lundbeck from 2004 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A$0.9348.4%
2024A$0.6329.29%
2023A$0.4923.09%
2022A$0.4037.26%
2021A$0.29-84.61%
2020A$1.87-24.61%
2019A$2.49-42.06%
2018A$4.2940.7%
2017A$3.05146.26%
2016A$1.24-120.48%
2015A-$6.053231.32%
2014A-$0.18-115.78%
2013A$1.15-23.36%
2012A$1.50-48.01%
2011A$2.89-9.68%
2010A$3.2013.72%
2009A$2.8124.32%
2008A$2.26-6.05%
2007A$2.4181.77%
2006A$1.32-16.76%
2005A$1.59-17.58%
2004A$1.93